The reviewed record of science sign in
Pith

arxiv: 2308.07413 · v1 · pith:HKLFDWYF · submitted 2023-08-14 · q-bio.BM

Benchmarking Generated Poses: How Rational is Structure-based Drug Design with Generative Models?

Reviewed by Pithpith:HKLFDWYFopen to challenge →

classification q-bio.BM
keywords generatedmethodsmoleculedruggenerativemoleculesworkdesign
0
0 comments X
read the original abstract

Deep generative models for structure-based drug design (SBDD), where molecule generation is conditioned on a 3D protein pocket, have received considerable interest in recent years. These methods offer the promise of higher-quality molecule generation by explicitly modelling the 3D interaction between a potential drug and a protein receptor. However, previous work has primarily focused on the quality of the generated molecules themselves, with limited evaluation of the 3D molecule \emph{poses} that these methods produce, with most work simply discarding the generated pose and only reporting a "corrected" pose after redocking with traditional methods. Little is known about whether generated molecules satisfy known physical constraints for binding and the extent to which redocking alters the generated interactions. We introduce PoseCheck, an extensive analysis of multiple state-of-the-art methods and find that generated molecules have significantly more physical violations and fewer key interactions compared to baselines, calling into question the implicit assumption that providing rich 3D structure information improves molecule complementarity. We make recommendations for future research tackling identified failure modes and hope our benchmark can serve as a springboard for future SBDD generative modelling work to have a real-world impact.

This paper has not been read by Pith yet.

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Forward citations

Cited by 5 Pith papers

Reviewed papers in the Pith corpus that reference this work. Sorted by Pith novelty score.

  1. Probe Before You Edit: Probing-Guided Molecular Optimization for LLM Agents in Structure-Based Drug Design

    cs.AI 2026-05 unverdicted novelty 7.0

    PROBE uses edit-response probing to build site maps and EditManuals that guide multi-agent LLM optimization, achieving SOTA performance on CrossDocked2020 while mitigating joint-improvement failures.

  2. From Holo Pockets to Electron Density: GPT-style Drug Design with Density

    cs.AI 2026-05 unverdicted novelty 7.0

    EDMolGPT generates drug-like molecules from low-resolution electron density point clouds of holo binding pockets and shows effectiveness across 101 biological targets.

  3. Demystifying Multimodal Biomolecular Co-design With Intrinsic Geodesic Coupling

    q-bio.BM 2026-06 unverdicted novelty 6.0

    GeoCoupling optimizes temporal couplings between modalities in biomolecular generative models and outperforms synchronous baselines on drug design and protein design tasks.

  4. Fine-tuning Pocket-Aware Diffusion Models via Denoising Policy Optimization

    cs.LG 2026-05 unverdicted novelty 6.0

    DEPPA reformulates the denoising process of pocket-aware diffusion models as a multi-step MDP and applies RL fine-tuning with a coarse scheduler to optimize ligands for binding affinity, drug-likeness, synthesizabilit...

  5. From Holo Pockets to Electron Density: GPT-style Drug Design with Density

    cs.AI 2026-05 unverdicted novelty 6.0

    EDMolGPT generates molecules from low-resolution electron density for de novo structure-based drug design, claiming better performance than pocket-based methods on 101 targets.